Percutaneous bone biopsy in the patient with known or suspected osseous metastases

Radiology. 1986 Oct;161(1):191-4. doi: 10.1148/radiology.161.1.3763865.

Abstract

One hundred fifty-three percutaneous bone biopsies were performed on 70 patients with and 83 patients without a known extraosseous primary tumor who had either scintigraphic evidence or plain radiographic evidence suggesting bony metastases. Biopsy results were shown to be true-negative, true-positive, or false-negative based on results of the needle biopsy, open biopsy, or radiographic follow-up. The overall accuracy of biopsy was 95.4%. In the group with positive scans only, the accuracy was 85.7%. Twenty-nine percent of the patients with known cancer and 33.7% of patients without cancer proved to have benign causes for their radiographic abnormality. The rate of significant complications was 0.7%. Biopsy of suspect osseous lesions can be performed safely and may significantly alter treatment. Biopsy of scan-positive, radiograph-negative lesions is a highly accurate procedure.

MeSH terms

  • Biopsy
  • Bone Neoplasms / diagnostic imaging
  • Bone Neoplasms / pathology*
  • Bone Neoplasms / secondary
  • Breast Neoplasms / pathology
  • Carcinoma / pathology*
  • Carcinoma / secondary
  • False Negative Reactions
  • Humans
  • Lung Neoplasms / pathology
  • Lymphatic Metastasis
  • Lymphoma / pathology
  • Lymphoma / secondary
  • Tomography, X-Ray Computed